Josh Duhamel, Dr. Gabrielle Lyon join Generation Iron testosterone documentary

Generation Iron has announced Longevity Code: The Truth About Testosterone, a new Vlad Yudin-directed documentary now in production and expected in 2027. The film will examine testosterone therapy for men and women as the FDA rethinks parts of the hormone-treatment landscape.

Why it matters: - Testosterone therapy is moving deeper into the mainstream medical conversation as FDA policy, research and public interest continue to shift. - The documentary aims to explain a topic that affects hormone health, aging, quality of life and, potentially, treatment options for both men and women. - The film also enters a debate with real-world consequences, including whether women should have an FDA-approved testosterone product.

What happened: - Generation Iron announced Longevity Code: The Truth About Testosterone, a feature documentary directed by Vlad Yudin. - The film is currently in production and is expected to release in 2027. - The project features Josh Duhamel, Dr. Gabrielle Lyon, Dr. Kelly Casperson, Don Saladino, Dave Asprey, John McPhee and Dr. Abraham Morgentaler, among others. - The documentary looks at the science, history, medical uses, controversies and future of testosterone therapy.

The details: - The film will examine declining hormone levels, the science behind testosterone and the growing interest in testosterone replacement therapy. - The project will also address questions around safety, medical appropriateness, differences between treatment forms and possible benefits for women. - The documentary explores recent FDA actions reconsidering long-standing labeling and indications for testosterone therapy. - Shalin Shah, CEO of Marius Pharmaceuticals, appears as one of the key voices in the film. - Marius Pharmaceuticals developed KYZATREX, an FDA-approved oral testosterone therapy. - Shah has pushed for broader access to testosterone therapy and for FDA approval of testosterone treatment for women. - Generation Iron said future announcements about featured experts, participants, release plans and distribution will come as production continues.

Between the lines: - The project reflects a broader pivot in testosterone coverage, from niche men’s health topic to a larger longevity and aging discussion. - The inclusion of physicians, researchers, public figures and patients suggests the film is trying to bridge clinical evidence with cultural debate. - The focus on women’s health signals where the next major regulatory and medical fight may land. - Generation Iron is widening its slate beyond bodybuilding into health, human performance, science and longevity storytelling.

What's next: - More cast, distribution and release details are expected as production moves forward. - The film will likely track how new research and FDA decisions shape future testosterone treatment options. - Viewers will get a broader argument over whether testosterone therapy should expand, stay limited or be redefined for different patient groups.

The bottom line: - Longevity Code is positioning testosterone therapy as the next major longevity and hormone-health story, with medical, regulatory and cultural stakes still unfolding.